Mexican race-walker Ms Gonzalez Romero issued 4 year doping ban


A decision in the matter of the International Association of Athletics Federations (IAAF) v Ms Maria Guadalupe Gonzalez Romero has been issued by the Disciplinary Tribunal. Ms Gonzalez Romero a Mexican race-walker was charged by the Athletics Integrity Unit (AIU) under the IAAF Anti-Doping Rules (ADR) after testing positive for the presence and use of the prohibited substance epitrenbolone (a metabolite of trenbolone) in a urine sample collected 17 October 2018.

On 17 April 2019, a hearing was held before the Panel, comprised of Mr Juan Pablo Arriagada Aljaro as the Sole Adjudicator. The Sole Adjudicator found that the Athlete had committed an Anti-Doping Rule Violation under Article 2.1 and 2.2 ADR and a four (4) year period of Ineligibility has been imposed upon the Athlete commencing on the date of the Award.  

The secretariat to the Disciplinary Tribunal is managed by Sport Resolutions.

A copy of the full decision can be accessed via the related links tab on the right-hand side.

To go to the AIU's website please click here.

You may also like

View All

ITIA v Irina Fetecău

A decision in the case of International Tennis Integrity Agency (ITIA) against Irina Fetecău has been issued by the Independent Panel

Read More

Latest court filings to impose roster limits for every NCAA sport

Latest court filings could result in an NCAA settlement approval which would mean that every NCAA sport must abide by roster limits, but the settlement also includes legislation which may enable student-athletes to receive more money

Read More

Clean Sport Week, led by UK Anti-Doping, to take place 19–23 May

Clean Sport Week 2025, focused on educating and empowering the next generation of athletes, will begin with an in-person panel event at Manchester Metropolitan University on Monday 19 May. The event will bring together emerging athletes and industry leaders to explore clean sport and the future of fair competition

Read More

Newsletter Signup

Please enter your email address below: